References
- Bhatt AS, Moscone A, McElrath EE, et al. Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 Jul 21;76(3):280–288. doi: 10.1016/j.jacc.2020.05.038
- Grines CL. SCAI consumer survey comparing fear of COVID-19 versus heart attack or stroke (first publish date: September 4, 2020). Catheter Cardiovasc Interv. 2021 Feb 1;97(2):193–194. doi: 10.1002/ccd.29419
- Garcia S, Stanberry L, Schmidt C, et al. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2021 Aug 1;98(2):217–222. doi: 10.1002/ccd.29154
- Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular Deaths During the COVID-19 Pandemic in the United States. J Am Coll Cardiol. 2021 Jan 19;77(2):159–169. doi: 10.1016/j.jacc.2020.10.055
- Ferreira D, Graffen S, Watkins B, et al. Effects of lockdown on acute coronary syndrome incidence in an area without community transmission of COVID-19. Open Heart. 2021;8(1):
e001692 . doi: 10.1136/openhrt-2021-001692 - Solomon MD, Nguyen-Huynh M, Leong TK, et al. Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges. JAMA. 2021;326(1):82–84. doi:10.1001/jama.2021.8414
- Yong CM, Ang L, Welt FGP, et al. Cardiac procedural deferral during the coronavirus (COVID-19) pandemic. Catheter Cardiovasc Interv. 2020 Nov;96(5):1080–1086. doi: 10.1002/ccd.29262
- Gramegna M, Baldetti L, Beneduce A, et al. ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub. Circ Cardiovasc Interv. 2020 Aug;13(8):
e009413 . doi: 10.1161/CIRCINTERVENTIONS.120.009413 - Kite TA, Ludman PF, Gale CP, et al. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol. 2021 May 25;77(20):2466–2476. doi: 10.1016/j.jacc.2021.03.309
- Butala N, Patel NK, Chhatwal J, et al. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis. Circ Cardiovasc Interv. 2020 Nov;13(11):
e010027 . doi: 10.1161/CIRCINTERVENTIONS.120.010027 - Wallace DW, Burleson SL, Heimann MA, et al. An adapted emergency department triage algorithm for the COVID-19 pandemic. J Am Coll Emerg Physicians Open. 2020 Aug 10;1(6):1374–1379. doi: 10.1002/emp2.12210
- Wee LEI, Conceicao EP, Tan JY, et al. Unintended consequences of infection prevention and control measures during COVID-19 pandemic. Am J Infect Control. 2021;49(4):469–477. doi:10.1016/j.ajic.2020.10.019
- Blomkalns AL, Gibler WB. Markers and the initial triage and treatment of patients with chest pain. Cardiovasc Toxicol. 2001;1(2):111–5. doi: 10.1385/ct:1:2:111
- Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May;109(5):531–538. doi: 10.1007/s00392-020-01626-9
- Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811–818. doi: 10.1001/jamacardio.2020.1017
- Sandoval Y, Januzzi JL, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Sep 8;76(10):1244–1258. doi: 10.1016/j.jacc.2020.06.068
- Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med. 2020 Jun 18;382(25):2478–2480. doi: 10.1056/NEJMc2009020
- Garcia S, Dehghani P, Grines C, et al. Initial Findings From the North American COVID-19 Myocardial Infarction Registry. J Am Coll Cardiol. 2021 Apr 27;77(16):1994–2003. doi: 10.1016/j.jacc.2021.02.055
- Mihatov N, Kirtane AJ. Standards of Care in Crisis: ST-Segment-Elevation Myocardial Infarction Management in COVID-19. Circ Cardiovasc Interv. 2020 Nov;13(11):
e010143 . doi: 10.1161/CIRCINTERVENTIONS.120.010143 - Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020 May 14;41(19):1801–1803. doi: 10.1093/eurheartj/ehaa235
- Danser AHJ, Epstein M, Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension. 2020 Jun;75(6):1382–1385. doi: 10.1161/HYPERTENSIONAHA.120.15082
- Lopes RD, Macedo AVS, de Barros E Silva PGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19. JAMA. 2021 Jan 19;325(3):254–264. doi: 10.1001/jama.2020.25864
- Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. 2003 Jan 4;361(9351):13–20. doi: 10.1016/S0140-6736(03)12113-7
- Mahmud E, Dauerman HL, Welt FGP, et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol. 2020;76(11):1375–1384. doi: 10.1016/j.jacc.2020.04.039
- Choudry FA, Hamshere SM, Rathod KS, et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020 Sep 8;76(10):1168–1176. doi: 10.1016/j.jacc.2020.07.022
- Elbadawi A, Mahtta D, Elgendy IY, et al. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era. JACC Cardiovasc Interv. 2020 Oct 12;13(19):2312–2314. doi: 10.1016/j.jcin.2020.07.004
- Richterman A, Meyerowitz EA, Cevik M. Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health. JAMA. 2020 Dec 1;324(21):2155–2156. doi: 10.1001/jama.2020.21399
- Shavadia JS, Chen AY, Fanaroff AC, de Lemos JA, Kontos MC, Wang TY. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion. JACC Cardiovasc Interv. 2019 Apr 22;12(8):709–717. doi: 10.1016/j.jcin.2019.01.230
- Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005 May 3;45(9):1397–405. doi: 10.1016/j.jacc.2005.01.041
- De Luca G, Suryapranata H, van’t Hof AWJ, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004 Jun 8;109(22):2737–43. doi: 10.1161/01.CIR.0000131765.73959.87
- Mercado MG, Smith DK, McConnon ML. Myocardial infarction: management of the subacute period. Am Fam Physician. 2013 Nov 1;88(9):581–8. PMID: 24364634
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–2615. doi: 10.1056/NEJMoa2034577
- Kadri SS, Simpson SQ. Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals. 2021 Sep 21;326(11):1003–1004. doi: 10.1001/jama.2021.13941
- Kichloo A, Albosta M, Dettloff K, et al. Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Community Health. 2020 Aug;8(3):
e000530 . doi: 10.1136/fmch-2020-000530
DOI: https://doi.org/10.14797/mdcvj.1049 | Journal eISSN: 1947-6108
Language: English
Page range: 16 - 21
Submitted on: Oct 8, 2021
Accepted on: Oct 26, 2021
Published on: Dec 15, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2021 Ronak Bahuva, Joe Aoun, Sachin S. Goel, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.